维普中文期刊产品整合服务
18篇 您的检索式:作者名="Hatoum HT"
    题名 作者 年代 出处 被引量
1Comparative clinical effectiveness of various 5-HT3 RA antiemetic regimens on chemotherapy-induced nausea and vomiting associated with hospital and emergency department visits in real world practice显示文摘Hatoum HT Lin S J Buchner D 2012Support Care Cancer2012,20,5:1
2Obrago: Patient Counseling--enhancing patient outcomes显示文摘Hatoum HT Hutchinson RA Lambert BL 1993US Pharm1993,18,7:1
3Treatment persistence with monthly zoledronic acid is associated with lower risk and frequency of skeletal complications in patients with breast cancer and bone metastasis显示文摘Hatoum HT Lin SJ Smith MR 0,,03:1
4OBRA 90: patient counseling enhancing patient outcomes显示文摘Hatoum HT Hutchinson RA Lambert BL 1993US Pharm1993,,:1
5Cost-effectiveness a-nalysis of intra-articular injections of a high molecular weight bioengineered hyaluronic acid for the treatment of osteoarthritis knee pain 显示文摘Hatoum HT Fierlinger AL Lin SJ 2014Journal of medical economics2014,17,5:1
6The impact of zoledronic acid treatment on frequency of skeletal complications experienced and on follow up duration post diagnosis of bone metastasis in lung cancer patients显示文摘Hatoum HT Lin S Lipton A 2008J Clin Oncol2008,26,15:1
7Zoledronic acid and skeletal complications in patients with solid tumors and bone metasta- ses: analysis of a national medical claims database显示文摘Hatoum HT Lin SJ Smith MR 2008Cancer2008,113,6:1
8Obrago:Patient Coun seling--enhancing patient outcomes 显示文摘Hatoum HT Hutchinson RA Lambert BL 1993US Phann1993,18,7:1
9Guide-lines for the Surgical Management of Traumatic Brain Injury Authou Group显示文摘Hatoum HT Fierlinger AL Lin S J 2014J Med Econ2014,3,2:1
10Zoledronic acid andskeletal complications in patients with solid tumors and bonemetastases : analysis of a national medical claims database 显示文摘Hatoum HT Lin SJ Smith MR 2008Cancer2008,113,:1
11Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study 显示文摘Lin S J Hatoum HT Buchner D 2012BMC Health Serv Res2012,12,8:1
12Zoledronie acid and skeletal complications in patients with solid tumors and bone metastases~ analysis of a national medical claims database显示文摘Hatoum HT Lin SJ Srnith MR 2008Cancer2008,113,6:1
13Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases:analysis of a National Medical claims database显示文摘Hatoum HT Lin SJ Smith MR 2008Cancer2008,113,6:1
14Physicials' review of significant interventions by clinical pharmacists in inpatient care显示文摘Hatoum HT Hutchinson RA Elliott LR 1988Drug Intell Clin Pharm1988,22,:1
15Evaluation of the contribution of clinical pharmacists:inpatient care and cost reduction显示文摘Hatoum HT Hutchinson RA Witte KW 1988Drug Intell and Clin Pharm1988,2,:1
16OBRA90: Patient Counseling - enhancing patient outcomes显示文摘Hatoum HT Hutchinson RA Lambert BL 1993US Pharm1993,18,7:1
17Obrago: Patient Counseling-enhancing patient outcomes 显示文摘Hatoum HT Hutchinson RA Lambert BL 1993US Pharm1993,18,7:1
18Persistency on monthly zoledronic acid impacts risk and frequency of skeletal complications and follow-up duration in lung cancer patients显示文摘Hatoum HT Lin S J Lipton A 2009J Thorac Oncol2009,4,91:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费